A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

NCT04257032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Rosuvastatin
DRUG: Rosuvastatin + BI 1323495
DRUG: Dabigatran etexilate
DRUG: Dabigatran etexilate + BI 1323495

Sponsor

Boehringer Ingelheim